ID SEPT1_HUMAN Reviewed; 372 AA. AC Q8WYJ6; B4DVE6; Q658T1; Q8NEZ1; Q96EL4; Q9H285; DT 16-APR-2002, integrated into UniProtKB/Swiss-Prot. DT 02-JUN-2021, sequence version 3. DT 24-JAN-2024, entry version 179. DE RecName: Full=Septin-1 {ECO:0000305}; DE AltName: Full=LARP; DE AltName: Full=Peanut-like protein 3; DE AltName: Full=Serologically defined breast cancer antigen NY-BR-24; GN Name=SEPTIN1 {ECO:0000312|HGNC:HGNC:2879}; GN Synonyms=DIFF6, PNUTL3, SEPT1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RA Tu Q., Yu L., Bi A., Zhang H., Zhao Y., Zhao S.; RT "Isolation and characterization of a novel human gene, HSLARP."; RL Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RA Peng J., Yu L.; RT "Molecular cloning and characterization of human septins which are RT expressed in liver."; RL Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases. RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). RC TISSUE=Spleen; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=B-cell; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 84-372. RC TISSUE=Stomach; RX PubMed=17974005; DOI=10.1186/1471-2164-8-399; RA Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., RA Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., RA Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., RA Wiemann S., Schupp I.; RT "The full-ORF clone resource of the German cDNA consortium."; RL BMC Genomics 8:399-399(2007). RN [6] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 98-372. RC TISSUE=Mammary gland; RX PubMed=12747765; RA Scanlan M.J., Gout I., Gordon C.M., Williamson B., Stockert E., Gure A.O., RA Jaeger D., Chen Y.-T., Mackay A., O'Hare M.J., Old L.J.; RT "Humoral immunity to human breast cancer: antigen definition and RT quantitative analysis of mRNA expression."; RL Cancer Immun. 1:4-4(2001). RN [7] RP SUBCELLULAR LOCATION, INTERACTION WITH AURKB, PHOSPHORYLATION AT SER-253; RP SER-312 AND SER-320, AND MUTAGENESIS OF SER-24; SER-211; SER-253; SER-312; RP SER-317 AND SER-320. RX PubMed=16179162; DOI=10.1016/j.bbrc.2005.06.212; RA Qi M., Yu W., Liu S., Jia H., Tang L., Shen M., Yan X., Saiyin H., Lang Q., RA Wan B., Zhao S., Yu L.; RT "Septin1, a new interaction partner for human serine/threonine kinase RT aurora-B."; RL Biochem. Biophys. Res. Commun. 336:994-1000(2005). RN [8] RP TISSUE SPECIFICITY. RX PubMed=15915442; DOI=10.1002/path.1789; RA Hall P.A., Jung K., Hillan K.J., Russell S.E.H.; RT "Expression profiling the human septin gene family."; RL J. Pathol. 206:269-278(2005). RN [9] RP SUBCELLULAR LOCATION. RX PubMed=19799413; DOI=10.1021/pr900325f; RA Chen T.C., Lee S.A., Hong T.M., Shih J.Y., Lai J.M., Chiou H.Y., Yang S.C., RA Chan C.H., Kao C.Y., Yang P.C., Huang C.Y.; RT "From midbody protein-protein interaction network construction to novel RT regulators in cytokinesis."; RL J. Proteome Res. 8:4943-4953(2009). RN [10] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-253 AND SER-320, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Leukemic T-cell; RX PubMed=19690332; DOI=10.1126/scisignal.2000007; RA Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., RA Rodionov V., Han D.K.; RT "Quantitative phosphoproteomic analysis of T cell receptor signaling RT reveals system-wide modulation of protein-protein interactions."; RL Sci. Signal. 2:RA46-RA46(2009). RN [11] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [12] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-211, AND IDENTIFICATION BY RP MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). CC -!- FUNCTION: Filament-forming cytoskeletal GTPase (By similarity). May CC play a role in cytokinesis (Potential). {ECO:0000250, ECO:0000305}. CC -!- SUBUNIT: Septins polymerize into heterooligomeric protein complexes CC that form filaments, and can associate with cellular membranes, actin CC filaments and microtubules. GTPase activity is required for filament CC formation (By similarity). Interacts with AURKB. {ECO:0000250, CC ECO:0000269|PubMed:16179162}. CC -!- INTERACTION: CC Q8WYJ6; A2BDD9: AMOT; NbExp=3; IntAct=EBI-693002, EBI-17286414; CC Q8WYJ6; Q4VCS5-2: AMOT; NbExp=3; IntAct=EBI-693002, EBI-3891843; CC Q8WYJ6; Q96GD4: AURKB; NbExp=6; IntAct=EBI-693002, EBI-624291; CC Q8WYJ6; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-693002, EBI-742054; CC Q8WYJ6; P59910: DNAJB13; NbExp=3; IntAct=EBI-693002, EBI-11514233; CC Q8WYJ6; Q9H8Y8: GORASP2; NbExp=3; IntAct=EBI-693002, EBI-739467; CC Q8WYJ6; Q86YR5-3: GPSM1; NbExp=3; IntAct=EBI-693002, EBI-10261098; CC Q8WYJ6; O75031: HSF2BP; NbExp=3; IntAct=EBI-693002, EBI-7116203; CC Q8WYJ6; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-693002, EBI-739832; CC Q8WYJ6; Q9UJV3-2: MID2; NbExp=3; IntAct=EBI-693002, EBI-10172526; CC Q8WYJ6; P52815: MRPL12; NbExp=3; IntAct=EBI-693002, EBI-358272; CC Q8WYJ6; Q9GZT8: NIF3L1; NbExp=3; IntAct=EBI-693002, EBI-740897; CC Q8WYJ6; Q9NRD5: PICK1; NbExp=3; IntAct=EBI-693002, EBI-79165; CC Q8WYJ6; Q9NWS0: PIH1D1; NbExp=3; IntAct=EBI-693002, EBI-357318; CC Q8WYJ6; O00560: SDCBP; NbExp=3; IntAct=EBI-693002, EBI-727004; CC Q8WYJ6; A0A0S2Z5W9: SEPT9; NbExp=3; IntAct=EBI-693002, EBI-16437910; CC Q8WYJ6; Q8WYJ6: SEPTIN1; NbExp=5; IntAct=EBI-693002, EBI-693002; CC Q8WYJ6; Q9NVA2: SEPTIN11; NbExp=3; IntAct=EBI-693002, EBI-957999; CC Q8WYJ6; Q8IYM1: SEPTIN12; NbExp=12; IntAct=EBI-693002, EBI-2585067; CC Q8WYJ6; Q9UH03: SEPTIN3; NbExp=3; IntAct=EBI-693002, EBI-727037; CC Q8WYJ6; Q99719: SEPTIN5; NbExp=13; IntAct=EBI-693002, EBI-373345; CC Q8WYJ6; Q14141: SEPTIN6; NbExp=9; IntAct=EBI-693002, EBI-745901; CC Q8WYJ6; Q8IYF3: TEX11; NbExp=3; IntAct=EBI-693002, EBI-742397; CC Q8WYJ6; Q7KZS0: UBE2I; NbExp=3; IntAct=EBI-693002, EBI-10180829; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cytoplasm, cytoskeleton CC {ECO:0000250}. Cytoplasm, cytoskeleton, microtubule organizing center, CC centrosome. Midbody. Note=Remains at the centrosomes and the nearby CC microtubules throughout mitosis. Localizes to the midbody during CC cytokinesis. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q8WYJ6-1; Sequence=Displayed; CC Name=2; CC IsoId=Q8WYJ6-2; Sequence=VSP_038269, VSP_038270; CC -!- TISSUE SPECIFICITY: Expressed at high levels in lymphoid and CC hematopoietic tissues. {ECO:0000269|PubMed:15915442}. CC -!- SIMILARITY: Belongs to the TRAFAC class TrmE-Era-EngA-EngB-Septin-like CC GTPase superfamily. Septin GTPase family. {ECO:0000255|PROSITE- CC ProRule:PRU01056}. CC -!- SEQUENCE CAUTION: CC Sequence=AAH12161.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=AAK61491.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=AAL40393.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC Sequence=BAG62658.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF085235; AAL40393.1; ALT_INIT; mRNA. DR EMBL; AY034176; AAK61491.1; ALT_INIT; mRNA. DR EMBL; AK301045; BAG62658.1; ALT_INIT; mRNA. DR EMBL; BC012161; AAH12161.1; ALT_INIT; mRNA. DR EMBL; AL833004; CAH56484.1; -; mRNA. DR EMBL; AF308288; AAG48256.1; -; Genomic_DNA. DR CCDS; CCDS10678.4; -. [Q8WYJ6-1] DR RefSeq; NP_443070.5; NM_052838.4. [Q8WYJ6-1] DR PDB; 6WBE; X-ray; 2.10 A; A/B/C/D=333-362. DR PDBsum; 6WBE; -. DR AlphaFoldDB; Q8WYJ6; -. DR SMR; Q8WYJ6; -. DR BioGRID; 108075; 44. DR IntAct; Q8WYJ6; 43. DR STRING; 9606.ENSP00000324511; -. DR iPTMnet; Q8WYJ6; -. DR MetOSite; Q8WYJ6; -. DR PhosphoSitePlus; Q8WYJ6; -. DR BioMuta; SEPT1; -. DR DMDM; 20178107; -. DR EPD; Q8WYJ6; -. DR jPOST; Q8WYJ6; -. DR MassIVE; Q8WYJ6; -. DR MaxQB; Q8WYJ6; -. DR PaxDb; 9606-ENSP00000324511; -. DR PeptideAtlas; Q8WYJ6; -. DR ProteomicsDB; 75160; -. [Q8WYJ6-1] DR ProteomicsDB; 75161; -. [Q8WYJ6-2] DR Antibodypedia; 27233; 310 antibodies from 31 providers. DR DNASU; 1731; -. DR Ensembl; ENST00000321367.8; ENSP00000324511.5; ENSG00000180096.13. [Q8WYJ6-1] DR Ensembl; ENST00000652617.2; ENSP00000498586.2; ENSG00000180096.13. [Q8WYJ6-1] DR GeneID; 1731; -. DR KEGG; hsa:1731; -. DR MANE-Select; ENST00000321367.8; ENSP00000324511.5; NM_001365977.2; NP_001352906.1. DR AGR; HGNC:2879; -. DR CTD; 1731; -. DR DisGeNET; 1731; -. DR GeneCards; SEPTIN1; -. DR HGNC; HGNC:2879; SEPTIN1. DR HPA; ENSG00000180096; Tissue enhanced (intestine, lymphoid tissue). DR MIM; 612897; gene. DR neXtProt; NX_Q8WYJ6; -. DR OpenTargets; ENSG00000180096; -. DR PharmGKB; PA24354; -. DR VEuPathDB; HostDB:ENSG00000180096; -. DR eggNOG; KOG2655; Eukaryota. DR GeneTree; ENSGT00940000161794; -. DR InParanoid; Q8WYJ6; -. DR PhylomeDB; Q8WYJ6; -. DR TreeFam; TF101079; -. DR PathwayCommons; Q8WYJ6; -. DR SignaLink; Q8WYJ6; -. DR BioGRID-ORCS; 1731; 1 hit in 988 CRISPR screens. DR ChiTaRS; SEPT1; human. DR GeneWiki; SEPT1; -. DR GenomeRNAi; 1731; -. DR Pharos; Q8WYJ6; Tdark. DR PRO; PR:Q8WYJ6; -. DR Proteomes; UP000005640; Chromosome 16. DR RNAct; Q8WYJ6; Protein. DR Bgee; ENSG00000180096; Expressed in granulocyte and 116 other cell types or tissues. DR ExpressionAtlas; Q8WYJ6; baseline and differential. DR GO; GO:0032153; C:cell division site; IBA:GO_Central. DR GO; GO:0005813; C:centrosome; IEA:UniProtKB-SubCell. DR GO; GO:0072687; C:meiotic spindle; IEA:Ensembl. DR GO; GO:0015630; C:microtubule cytoskeleton; IBA:GO_Central. DR GO; GO:0030496; C:midbody; IDA:HGNC. DR GO; GO:0031105; C:septin complex; IBA:GO_Central. DR GO; GO:0005940; C:septin ring; IBA:GO_Central. DR GO; GO:0008021; C:synaptic vesicle; IBA:GO_Central. DR GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW. DR GO; GO:0003924; F:GTPase activity; IBA:GO_Central. DR GO; GO:0042802; F:identical protein binding; IPI:IntAct. DR GO; GO:0060090; F:molecular adaptor activity; IBA:GO_Central. DR GO; GO:0061640; P:cytoskeleton-dependent cytokinesis; IBA:GO_Central. DR GO; GO:0051311; P:meiotic metaphase chromosome alignment; IEA:Ensembl. DR GO; GO:0017157; P:regulation of exocytosis; IBA:GO_Central. DR GO; GO:0007056; P:spindle assembly involved in female meiosis; IEA:Ensembl. DR CDD; cd01850; CDC_Septin; 1. DR Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1. DR InterPro; IPR030379; G_SEPTIN_dom. DR InterPro; IPR027417; P-loop_NTPase. DR InterPro; IPR016491; Septin. DR PANTHER; PTHR18884; SEPTIN; 1. DR PANTHER; PTHR18884:SF6; SEPTIN-1; 1. DR Pfam; PF00735; Septin; 1. DR PIRSF; PIRSF006698; Septin; 1. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1. DR PROSITE; PS51719; G_SEPTIN; 1. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Cell cycle; Cell division; Cytoplasm; KW Cytoskeleton; GTP-binding; Nucleotide-binding; Phosphoprotein; KW Reference proteome. FT CHAIN 1..372 FT /note="Septin-1" FT /id="PRO_0000173513" FT DOMAIN 27..301 FT /note="Septin-type G" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01056" FT REGION 37..44 FT /note="G1 motif" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01056" FT REGION 94..97 FT /note="G3 motif" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01056" FT REGION 175..178 FT /note="G4 motif" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01056" FT REGION 352..372 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 354..372 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 37..44 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250" FT BINDING 71 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250" FT BINDING 97 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250" FT BINDING 176..184 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250" FT BINDING 234 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250" FT BINDING 250 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT /evidence="ECO:0000250" FT MOD_RES 211 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:24275569" FT MOD_RES 253 FT /note="Phosphoserine; by AURKB" FT /evidence="ECO:0000269|PubMed:16179162, FT ECO:0007744|PubMed:19690332" FT MOD_RES 256 FT /note="Phosphothreonine" FT /evidence="ECO:0000250|UniProtKB:P42209" FT MOD_RES 312 FT /note="Phosphoserine; by AURKB" FT /evidence="ECO:0000269|PubMed:16179162" FT MOD_RES 320 FT /note="Phosphoserine; by AURKB" FT /evidence="ECO:0000269|PubMed:16179162, FT ECO:0007744|PubMed:19690332" FT VAR_SEQ 153..172 FT /note="LRPLDVAFLRAVHEKVNIIP -> SGGGILGAGAFREGWGVSAP (in FT isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_038269" FT VAR_SEQ 173..372 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:14702039" FT /id="VSP_038270" FT VARIANT 85 FT /note="G -> V (in dbSNP:rs34518080)" FT /id="VAR_051934" FT MUTAGEN 24 FT /note="S->A: No effect on phosphorylation." FT /evidence="ECO:0000269|PubMed:16179162" FT MUTAGEN 211 FT /note="S->A: No effect on phosphorylation." FT /evidence="ECO:0000269|PubMed:16179162" FT MUTAGEN 253 FT /note="S->A: Great reduction in phosphorylation." FT /evidence="ECO:0000269|PubMed:16179162" FT MUTAGEN 312 FT /note="S->A: Great reduction in phosphorylation." FT /evidence="ECO:0000269|PubMed:16179162" FT MUTAGEN 317 FT /note="S->A: No effect on phosphorylation." FT /evidence="ECO:0000269|PubMed:16179162" FT MUTAGEN 320 FT /note="S->A: Great reduction in phosphorylation." FT /evidence="ECO:0000269|PubMed:16179162" FT CONFLICT 65 FT /note="S -> G (in Ref. 1; AAL40393)" FT /evidence="ECO:0000305" FT CONFLICT 153..155 FT /note="LRP -> SR (in Ref. 1; AAL40393)" FT /evidence="ECO:0000305" FT CONFLICT 245..246 FT /note="RP -> GL (in Ref. 1; AAL40393)" FT /evidence="ECO:0000305" FT CONFLICT 329 FT /note="L -> P (in Ref. 1; AAL40393)" FT /evidence="ECO:0000305" FT HELIX 334..360 FT /evidence="ECO:0007829|PDB:6WBE" SQ SEQUENCE 372 AA; 42386 MW; 00F2752A819E1F16 CRC64; MAGGVMDKEY VGFAALPNQL HRKSVKKGFD FTLMVAGESG LGKSTLINSL FLTNLYEDRQ VPEASARLTQ TLAIERRGVE IEEGGVKVKL TLVDTPGFGD SVDCSDCWLP VVKFIEEQFE QYLRDESGLN RKNIQDSRVH CCLYFISPFG RGLRPLDVAF LRAVHEKVNI IPVIGKADAL MPQETQALKQ KIRDQLKEEE IHIYQFPECD SDEDEDFKRQ DAEMKESIPF AVVGSCEVVR DGGNRPVRGR RYSWGTVEVE NPHHCDFLNL RRMLVQTHLQ DLKEVTHDLL YEGYRARCLQ SLARPGARDR ASRSKLSRQS ATEIPLPMLP LADTEKLIRE KDEELRRMQE MLEKMQAQMQ QSQAQGEQSD AL //